secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2024-01-31T23:59:59+00:00
Accession:  0001104659-24-008825
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma transfers listing to Nasdaq Capital Market to regain bid price compliance
--------------------------------------------------------------------------------

- Received Nasdaq approval to transfer common stock listing from Global Select Market to Capital Market effective Feb 1, 2024.
- Granted a second 180-day compliance period until July 29, 2024 to meet $1.00 minimum bid price requirement.
- Company must close at $1.00 per share for 10 consecutive business days to regain compliance.
- If compliance not achieved by July 29, 2024, Nasdaq may delist the stock; Company may appeal.
- Company intends to cure deficiency via a reverse stock split if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/0001104659-24-008825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465924008825/tm244750d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-008825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer